Other
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
CVS Health Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax increased by 35.0% to $447M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.3%, from $547M to $447M. Over 5 years (FY 2020 to FY 2025), Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax shows an upward trend with a 97.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2018
Last reportedQ1 2026May 6, 2026
Metric ID:
other_available_for_sale_debt_securities_accumulated_gro_6005e2Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $32M | $55M | $106M | $726M | $1.52B | $2.23B | $1.84B | $1.39B | $1.43B | $1.74B | $836M | $873M | $863M | $453M | $707M | $547M | $449M | $332M | $331M | $447M |
| QoQ Change | — | +71.9% | +92.7% | +584.9% | +108.7% | +46.9% | -17.3% | -24.3% | +2.9% | +21.1% | -51.8% | +4.4% | -1.1% | -47.5% | +56.1% | -22.6% | -17.9% | -26.1% | -0.3% | +35.0% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | +91.9% | -5.4% | -22.0% | -54.6% | -37.3% | -39.8% | -73.9% | -15.4% | -37.3% | -48.0% | -26.7% | -53.2% | -18.3% |
Range$32M – $2.23B
CAGR+74.2%
Avg YoY Growth+617.2%
Median YoY Growth-24.4%
Product Breakdown
| Segment | Q4 '25 |
|---|---|
| Supporting Experience-Rated Products | $16M |
| Total | $331M |
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax at Other Companies
Frequently Asked Questions
- What is CVS Health's debt securities, available-for-sale, accumulated gross unrealized loss, before tax?
- CVS Health (CVS) reported debt securities, available-for-sale, accumulated gross unrealized loss, before tax of $447M in Q1 2026.
- How has CVS Health's debt securities, available-for-sale, accumulated gross unrealized loss, before tax changed year-over-year?
- CVS Health's debt securities, available-for-sale, accumulated gross unrealized loss, before tax decreased by 18.3% year-over-year, from $547M to $447M.
- What is the long-term trend for CVS Health's debt securities, available-for-sale, accumulated gross unrealized loss, before tax?
- Over 5 years (2020 to 2025), CVS Health's debt securities, available-for-sale, accumulated gross unrealized loss, before tax has grown at a 97.6% compound annual growth rate (CAGR), from $11M to $331M.